Bank of New York Mellon Corp - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$8,577
-45.4%
26,311
-28.0%
0.00%
Q1 2023$15,722
-19.1%
36,562
-0.3%
0.00%
Q4 2022$19,431
-28.0%
36,662
-0.2%
0.00%
Q3 2022$27,000
-35.7%
36,743
+0.3%
0.00%
Q2 2022$42,000
-44.0%
36,643
-0.2%
0.00%
Q1 2022$75,000
-29.2%
36,7130.0%0.00%
Q4 2021$106,000
-32.1%
36,7130.0%0.00%
Q3 2021$156,000
+50.0%
36,713
+86.8%
0.00%
Q2 2021$104,000
+4.0%
19,657
-8.8%
0.00%
Q1 2021$100,000
+29.9%
21,552
-8.1%
0.00%
Q4 2020$77,000
+126.5%
23,454
+130.7%
0.00%
Q3 2020$34,0000.0%10,166
+0.0%
0.00%
Q2 2020$34,000
-86.0%
10,165
-84.0%
0.00%
Q1 2020$243,000
-40.9%
63,455
-6.7%
0.00%
Q4 2019$411,000
-11.4%
68,001
+10.6%
0.00%
Q3 2019$464,000
-41.2%
61,457
+5.4%
0.00%
Q2 2019$789,000
+172.1%
58,298
+75.0%
0.00%
Q1 2018$290,000
-27.1%
33,319
+4.7%
0.00%
Q4 2017$398,000
+32.2%
31,815
-11.8%
0.00%
Q3 2017$301,000
-50.0%
36,066
+1.5%
0.00%
Q2 2017$602,000
+145.7%
35,529
+192.1%
0.00%
Q1 2017$245,000
+36.1%
12,165
+5.5%
0.00%
Q4 2016$180,000
+160.9%
11,530
+13.8%
0.00%
Q2 2016$69,00010,1290.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ETF MANAGERS GROUP, LLC 3,662,342$7,874,0000.16%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 213,469$438,0000.07%
GSA CAPITAL PARTNERS LLP 150,914$309,0000.04%
Bernardo Wealth Planning LLC 30,469$62,0000.03%
Penserra Capital Management LLC 351,154$719,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,900$361,0000.01%
Founders Capital Management 3,000$9,0000.01%
King Wealth Management Group 16,000$33,0000.01%
Aquatic Capital Management LLC 1,900$4,0000.01%
Newbridge Financial Services Group, Inc. 6,075$12,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders